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ver the past 15 years, scientists
have produced an impressive
body of evidence highlighting
vitamin D’s central role in main-
taining health.1,2 As these dramatic
benefits were reported both in
health journals and the popular
press, many clinicians embraced
the findings by monitoring
patients’ vitamin D serum levels,
encouraging safe sun exposure, and
prescribing supplementation with
vitamin D as needed.2,3 But other
clinicians remained skeptical.4
The purpose of the Institute of
Medicine’s (IOM’s) Dietary Reference
Intakes for Calcium and Vitamin D
report5 was to re-evaluate Dietary
Reference Intakes (DRIs) for vita-
min D in light of thousands of
studies published since the last
report in 1997. The IOM report’s
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In November 2010, the Institute of Medicine (IOM) released Dietary Reference Intakes for
Calcium and Vitamin D, a radical departure from previous advice given regarding these two
nutrients that have been reported in respected health journals. The 14-member expert commit-
tee found clear and convincing evidence to support the association between adequate levels of
vitamin D and bone health. The IOM committee did not find enough evidence to support claims
that inadequate levels of vitamin D are linked to increased risks for cancer, cardiovascular
disease, or diabetes. In this article, the authors discuss the controversy surrounding vitamin D
and provide guidance for primary care nurse practitioners.
O
36  THE AMERICAN JOURNAL FOR NURSE PRACTITIONERS JANUARY/FEBRUARY 2012 VOL. 16 NO. 1/2
PRIMARY CARE
authors investigated the relation-
ship between calcium and vitamin
D intake and bone health.5 In addi-
tion, they ascertained whether low
vitamin D levels might be related to
increased risk for a wide variety of
diseases and conditions, including
cancer, cardiovascular disease, hy-
pertension, diabetes, metabolic syn-
drome, falls, asthma, inflammatory
bowel disease, Crohn’s disease, mul-
tiple sclerosis, rheumatoid arthritis,
systemic lupus erythematosus,
tuberculosis, influenza, upper respi-
ratory infections, autism, cognitive
function, depression, and pre-
eclampsia. Some studies showed that
low vitamin D levels were related to
increased risk for disease, but others
did not show this relationship.
Overall, the evidence was in-
conclusive in confirming the many
promising hypotheses regarding
the efficacy of vitamin D in pre-
venting a host of health problems.5
In the view of the 14-member
expert panel, evidence from ran-
domized controlled trials (RCTs)
was scant. The report increased the
Recommended Dietary Allowance
(RDA) for vitamin D, set the toler-
able Upper Intake Levels, high-
lighted emerging data pointing to
risks posed by high-dose vitamin D
supplements, and called for stan-
dardization of laboratory cut-
points for vitamin D deficiency. To
understand how the IOM reached
its conclusions, it is helpful to look
more closely at the history of
research into the health effects of
vitamin D.
History of Vitamin D Research
Vitamin D and bone health have
attracted scientific interest for
decades.1 Researchers have long
known that vitamin D is essential
to calcium and phosphorus regula-
tion, and that severe deficiencies
result in rickets and osteomalacia.
In the 1980s, epidemiologists
noticed an ominous trend, wherein
persons living at higher latitudes
with less sun exposure seemed to
have higher rates of cancer. As is
well known, exposure to the sun
helps the body produce vitamin D,
which is actually a hormone.6
Might there be a cause-and-effect
relationship between reduced vita-
min D levels and cancer risk?
Several long-term observational
studies, known collectively as the
Harvard cohort studies, were used
to investigate the role of vitamin D
in this regard.6 These studies
included the Nurses’ Health Study
I and II, the Health Professional
Follow-Up Study, and the Physi-
cians’ Health Study. These studies
have amassed information about
diet, lifestyle, and incidence of dis-
ease over the course of each partici-
pant’s lifetime. Blood samples were
collected, enabling investigators to
analyze participants’ vitamin D lev-
els and the incidence of various ill-
nesses. These studies generated a
treasure trove of information,
among which vitamin D’s efficacy
was but one key discovery. The
strongest evidence from the
Harvard cohort studies was the
relationship between decreasing
vitamin D levels and increasing
cancer risk. The Health Professional
Follow-Up Study showed that men
with deficient vitamin D levels were
at increased risk for a myocardial
infarction.7 In toto, data from these
and other studies focused major
attention on vitamin D.
Two extensive reports, Effective-
ness and Safety of Vitamin D in
Relation to Bone Health8 and Vitamin
D and Calcium: Systematic Review of
Health Outcomes,9 provided a criti-
cal analysis of the vitamin D scien-
tific literature and laid the
groundwork for the 2010 IOM
report. Regarded by many experts
as overly conservative, the thou-
sand-page IOM report has sparked
intense debate.10-12 The Harvard
School of Public Health published
Comment on IOM Vitamin D and
Calcium Recommendations: For Adult
Bone Health, Too Low on Vitamin
D—and Too Generous on Calcium13
on the school’s website, challenging
the IOM’s findings. According to the
Harvard website, the lack of RCTs
did not equate to lack of benefit.
The Endocrine Society released its
own set of clinical guidelines on the
evaluation, treatment, and preven-
tion of vitamin D deficiency.14 The
Endocrine Society task force, com-
prised of vitamin D experts,
acknowledged the overall low-qual-
ity of evidence but expressed hope
that the science would soon
advance and that recommendations
would soon be revised upward.
Incidence of Vitamin D Deficiency
in the US Population
Few patients present with evidence
of severe vitamin D deficiency such
as rickets or hypercalcemia.15
According to the IOM, the cut-point
for identifying vitamin D deficiency
is a serum 25-hydroxyvitamin D
(25OHD) level below 30 nmol/L
(<12 ng/mL).5 A 25OHD level of 50
nmol/L (20 ng/mL) is sufficient to
maintain bone health for most
Americans. The IOM’s cut-points
are much lower than the advice of
other experts, however. The Endo-
crine Society guidelines defined
vitamin D deficiency as a serum
25OHD level below 50 nmol/L (20
ng/mL) and suggested a minimum
25OHD level of 75 nmol/L (30
ng/mL) to obtain extra-skeletal ben-
efits.14 According to Holick,16 an
expert in the field and lead author
of the Endocrine Society guidelines,
25OHD levels of 52-72 nmol/L (21-
29 ng/mL) represent insufficiency.
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By these estimates, nearly 1 billion
persons worldwide are vitamin D
deficient.16 According to Ginde et
al,17 who used data from two
National Health and Nutrition
Examination Surveys, the mean
serum 25OHD level in the U.S.
decreased from 30 to 24 ng in a 10-
year period correlating with cam-
paigns to use sunscreens and avoid
sun exposure.
Older adults, obese individuals,
pregnant or lactating women, per-
sons with pigmented skin, and per-
sons with little or no sun exposure
are at high risk for vitamin D defi-
ciency.15,18 Dark-skinned persons, as
compared with fair-skinned per-
sons, require 5 times as much sun
exposure to produce the same
amount of vitamin D.19 African
Americans, compared with light-
skinned populations, have lower
serum 25OHD levels.5 Obesity is
associated with decreased vitamin
D levels because excess fat absorbs
and retains vitamin D, preventing it
from reaching cells and bones.2
Because the ability to synthesize
vitamin D decreases with age, per-
sons older than 60 years require 3-4
times more sun exposure than their
younger counterparts.1,19 Persons
using anticonvulsants, rifampicin,
or highly active antiretroviral drugs
are at high risk for vitamin D defi-
ciency because these drugs induce
the cytochrome P450 enzymes that
metabolize vitamin D.15
Dietary Reference Intakes
The Food and Nutrition Board of
the IOM sets the DRI standard for
nutritional requirements. Com-
ponents of the DRI include the
estimated average requirement,
RDAs, adequate intake levels, and
tolerable upper intake levels.5
RDAs are used to develop clinical
practice guidelines and to select
doses used in multivitamins and
fortified foods. New DRI values for
vitamin D were released in IOM
report, and are listed in Table 1.5
The increased RDA levels for vita-
min D are 600 IU/day for persons
aged 1-70 years and 800 IU/day for
those aged >70 years. The Endo-
crine Society guidelines regarding
vitamin D adequate intake levels
and upper intake levels differ from
those of the 2010 IOM report (see
references 5 and 14).5,14
Monitoring Vitamin D Levels
Signs and symptoms of vitamin D
deficiency are insidious or nonspe-
cific. As a result, they often go
unrecognized unless blood testing
is done.
Laboratory Testing—According
to the National Institutes of Health
(NIH),18 wide variability in mea-
suring vitamin D existed until July
2009, when a standard reference
of measurement became available.
Vitamin D levels are best repre-
sented by serum 25OHD,5 which
is measured by radioimmunoas-
say, enzyme-linked assays, or liq-
uid chromatography with mass
spectrometry.20
Routine Patient Screening—
According to the 2010 IOM report,5
routine blood screening for vita-
min D deficiency is not necessary
because most Americans have ade-
quate vitamin D levels. The
Endocrine Society recommends
screening for vitamin D only in per-
sons at risk for vitamin D deficien-
cy.14 For primary care practitioners
who added assessment of patients’
vitamin D status to their list of pre-
ventive health topics years ago, the
new guidelines have been cause for
confusion. Insurance companies
have reacted by stopping payment
or reimbursement for vitamin D
blood testing. On the strength of
VITAMIN D DIETARY REFERENCE INTAKES BY
LIFE STAGE5TABLE 1
VITAMIN D
Estimated Average Recommended
Requirement Dietary Allowance Upper Intake Level
Age (IU/day) (IU/day) (IU/day)
0-6 months * * 1000
6-12 months * * 1500
1-3 years 400 600 2500
4-8 years 400 600 3000
9-13 years 400 600 4000
14-18 years 400 600 4000
19-30 years 400 600 4000
31-50 years 400 600 4000
51-70 years (males) 400 600 4000
51-70 years (females) 400 600 4000
>70 years 400 800 4000
14-18 years (pregnant/lactating) 400 600 4000
19-50 years (pregnant/lactating) 400 600 4000
*For infants, Adequate Intake is 400 IU/day for those aged 0-6 months and 400 IU/day for those aged 6-12 months.
the IOM report, some clinicians
have suspended routine vitamin D
screening and recommendations
for vitamin D supplementation.20
Treating and Preventing
Vitamin D Deficiency
The scientific community has not
achieved consensus regarding the
optimal measures needed to treat
or prevent vitamin D deficiency,
which include dietary intake of
vitamin D, sun exposure, and vita-
min D supplementation. Table 2
summarizes current guidelines for
serum 25OHD cut-points, sun
exposure, and supplementation
from a number of prominent aca-
demic, professional, and govern-
mental groups.
Diet—The IOM has acknowl-
edged the difficulty of meeting
vitamin D requirements by diet
alone. Few foods naturally contain
vitamin D. Dietary sources of vita-
min D include fatty fish (eg, tuna,
salmon, mackerel), egg yolk,
mushrooms, and fish liver oil.18
Most dietary vitamin D in the
United States comes from fortified
foods such as breakfast cereals,
milk, and fruit juices and fruit
drinks. Fortified foods have enough
vitamin D to protect against rickets
and osteomalacia, the most severe
forms of vitamin D deficiency.
Persons with lactose intoler-
ance cannot digest dairy products
and may be at increased risk for
vitamin D deficiency. These indi-
viduals can ingest lactose-reduced
dairy products, non-dairy calcium-
rich foods, calcium supplements,
or lactase pills or drops to meet cal-
cium and vitamin D requirements.
38  THE AMERICAN JOURNAL FOR NURSE PRACTITIONERS JANUARY/FEBRUARY 2012 VOL. 16 NO. 1/2
PRIMARY CARE
SUMMARY OF GUIDANCE ON VITAMIN DTABLE 2
Guide Serum 25OHD Cut-points Sun Exposure Vitamin D Supplementation
Institute of Medicine (IOM)5 Deficiency Calls for investigation of a “minimal-risk Report states that most Americans are
30 nmol/L (12 ng/mL) UVB exposure.” The IOM asks, “Is it not vitamin D deficient and do not require
Inadequacy possible to create vitamin D synthesis supplements. Persons who are deficient
30-50 nmol/L (12-20 ng/mL) and avoid skin cancer risk?” The IOM and some with inadequacy require
Sufficiency considered incidental sun exposure treatment. Supplements recommended for
50 nmol/L (20 ng/mL) is all that is but wants more research on what is a persons with 25OHD levels <50 nmol/L
required to maintain bone health safe exposure of sun where people (<20 ng/mL).
Reason for concern could reap benefits without adverse
125 nmol/L (50 ng/mL)* effects. The IOM assumed “incidental”
sun exposure in its deliberations.
Endocrine Society14 Deficiency Suggests raising blood levels to more
Less than 50 nmol/L (20 ng/mL) than 75 nmol/L (30 ng/mL) to
obtain possible extra-skeletal benefits.
Harvard School of Public Adequate level Does not recommend unprotected 800-1000 IU/day; some persons may
Health10 75 nmol/L (30 ng/mL) sun exposure. need 2000 IU/day or more (eg, those with
dark skin, obesity, or little sun exposure).
American Academy of N/A Recommends protection at all times. N/A
Dermatology and AAD
Association21
Holick2,16 Deficiency Recommends sensible sun exposure: Determined by blood level. 1000 IU/day
Less than 50 nmol/L (20 ng/mL) formula based on skin type, latitude, recommended for non-deficient persons;
Insufficiency and season (eg, 10-15 min for a total daily intake target is 1500-2000 IU
52-72 nmol/L (21-29 ng/mL) fair-skinned person between 12 noon through all sources (diet, multivitamin,
Sufficiency and 2 pm during summertime); see supplements); see reference 2 for more
More than 75 nmol/L (30 ng/mL) reference 2 for more details. details.
To obtain full benefit for health
100 nmol/L (40 ng/mL)
International Osteoporosis Target N/A Based on blood test results, sun exposure,
Foundation22 75 nmol/L (30 ng/mL) for older body mass index; 2000 IU/day for persons
individuals with obesity, osteoporosis, limited sun
exposure (eg, institutionalized, homebound).
This table refers to recommendations for adults. It does not cover recommendations for newborns, children, pregnant woman, or persons with other health problems.
*The IOM found good evidence of adverse effects of very high doses of vitamin D.
Of note, calcium and vitamin D
work effectively only in tandem,
making adequate levels of both
substances essential. Unlike vita-
min D, calcium is easily obtained
through dietary sources, although
caffeine intake and medications
such as proton pump inhibitors
can have a negative effect on calci-
um levels.2
Sun Exposure—Sensible sun
exposure is the most efficient way
to obtain adequate levels of vita-
min D.23,24 A few minutes a day of
unprotected sun exposure in the
summer can help maintain ade-
quate levels of vitamin D through-
out the year.2 Sunlight includes
ultraviolet A (UVA) light and ultra-
violet B (UVB) light, the latter of
which is needed for production of
vitamin D. The degree of success in
obtaining vitamin D from UVB
rays depends on a variety of factors,
including the season, geography,
latitude, time of day, cloud cover,
smog level, amount of melanin
and sunscreen, and mobility and
access to the outdoors. Experts
maintain that generating adequate
levels of vitamin D through sun
exposure is impossible during the
winter months in cities located in
northern latitudes (eg, New York
City, Chicago). In addition, air pol-
lution and glass filter out UVB rays
that urban dwellers depend on for
vitamin D.24
Sensible sun exposure in a fair-
skinned person can be obtained by
sunbathing without sunscreen for
10-15 minutes between noon and
2 PM during the summer.2 Ex-
posing the face may not even be
necessary or desirable if one’s arms
and legs—25% of the body area—
receive sunlight. Moderation is key.
Any sun exposure causing erythema
(sunburn) is avoided because the
risk for melanoma increases. Many
office workers have schedules that
preclude them from spending any
time in the sun. Increasing their
sun exposure may mean walking
down the sunny side of the street,
eating lunch outside, or making
phone calls from a park bench.
Sun exposure has several
advantages over supplementation
as a source of vitamin D. First, one
cannot “overdose” on vitamin D
through too much exposure to the
sun.2 The body has a natural mech-
anism to cut off production of vita-
min D when a sufficient supply has
been generated. Even severe sun-
burn will not result in vitamin D
toxicity. Second, the body stores
excess vitamin D in fat and then
releases it during the winter
months when it is needed. Spend-
ing the summer in the sun stores
up vitamin D for gray and sunless
winters that effectively halt vitamin
D production.
Experts disagree about sun
exposure. The American Academy
of Dermatology issued a strong
policy statement in 2009 advising
patients to protect themselves
against the sun at all times.21 For
years, the public heeded the advice
of dermatologists to avoid all sun
exposure by using sunscreen and
wearing protective clothing. Com-
panies manufacturing sun-protec-
tion products used advertising to
reinforce the medical advice.
Anxious mothers dutifully covered
their children. Persons at risk for
skin cancer (eg, those with a history
of skin cancer, fair-skinned persons
with multiple nevi) conscientiously
avoided all sun exposure until new
research regarding the health bene-
fits of the sun came to light.2 Some
experts have acknowledged that
rates of skin cancer, including
melanoma, rise even with “sensi-
ble” sun exposure, but they argue
that the risk is worth taking because
of the overwhelming health bene-
fits of vitamin D.19 Increased skin
cancer screenings are offered as a
possible solution to cope with the
risks of increased sun exposure. The
IOM has identified the need to
research the issue of safe sun expo-
sure to produce vitamin D.
Supplementation—Getting suf-
ficient vitamin D from the sun is
not always possible. Vitamin D
supplements come in two forms,
ergocalciferol (vitamin D2) and
cholecalciferol (vitamin D3). The
efficacy of supplementation is well
documented.2 The Endocrine Soci-
ety endorses supplementation with
vitamin D2 or vitamin D3.14 Both
the Nutrition Source at the Harvard
School of Public Health and the
International Osteoporosis Founda-
tion endorse using D3 for supple-
mentation.10,22
However, consensus regarding
the recommended daily dose, or
even the need for vitamin D sup-
plementation, does not exist.2,5,20
The IOM does not recommend the
high levels of supplementation
endorsed by many vitamin D
experts.5 In fact, the IOM set 4000
IU/day as the upper tolerable limit
for safety. If a person exceeds a
daily dose of 4000 IU, the possibil-
ity of harm increases. The IOM was
clear that “more is not better,” cit-
ing emerging evidence that excess
intake of vitamin D is linked to all-
cause mortality, cancer, cardiovas-
cular risk, falls, and fractures.
Vitamin D supplements are
available over the counter (OTC) at
health food stores, pharmacies,
and grocery stores in strengths
ranging from 400 to 5000 IU.
Multivitamins are another source
of vitamin D. Holick recommends
vitamin D supplements of 1000-
2000 IU/day for most individuals.2
The Nutrition Source at the
Harvard School of Public Health
recommends higher daily doses
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(≥2000 IU) for persons who have
darker skin, spend winters in the
northern U.S., or have little expo-
sure to direct sunlight.10 For per-
sons with severe vitamin D
deficiency, much higher doses are
available by prescription. Vitamin
D toxicity, albeit quite rare, is man-
ifested by nausea, vomiting, poor
appetite, constipation, increased
thirst, depression, increased urina-
tion, and/or weight loss.16
Conclusion
The IOM report concluded that the
available current evidence base was
not sufficient to establish causal
links between vitamin D and a
host of diseases and that too much
vitamin D can be harmful.5 The
IOM has outlined a blueprint for
further research to explore the
promising hypotheses that exist
regarding the efficacy of vitamin D.
RCTs with the potential to answer
questions posed by the IOM report
are already in progress. The Vita-
min D and Omega-3 Trial (VITAL),
an RCT, began enrolling patients in
January 2010.25 This study, funded
by the NIH, is investigating the role
of dietary vitamin D supplements
or fish oil in reducing risks for can-
cer, heart disease, and stroke.
Vitamin D has received much
attention because of its numerous
anticancer properties, including
reduced proliferation, invasiveness,
angiogenesis, and metastasis, and
increased differentiation and apop-
tosis.6,26 Laboratory animal experi-
ments involving the anticancer
properties of vitamin D have pro-
vided encouraging results.5
The public health implications
of the vitamin D debates are pro-
found, because inexpensive mea-
sures such as sensible sun exposure,
supplementation, and diet can pre-
vent disease worldwide by main-
taining and restoring adequate
levels of vitamin D. Practices relat-
ing to sun avoidance and sun pro-
tection appear to have spread, and
have had the unintended conse-
quences with respect to vitamin D
levels, which have plummeted over
the past 30 years.27 Until strict “no
sun” policies were promulgated by
dermatologists starting in the
1970s, most of the public co-exist-
ed happily with the sun. From an
evolutionary perspective, the sun
has been and will continue to be
central to human existence.
Nurse practitioners need to
keep pace with the rapid advances
in knowledge of vitamin D. Much
of the data being amassed is
encouraging and useful for engag-
ing patients in a culturally sensitive
dialogue. The outcome of this dia-
logue must be informed decisions
by patients regarding safe sun
exposure, dietary sources of calci-
um and vitamin D, and safe sup-
plementation. 
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